Clinical trials in Michalovce

Comprehensive studies focusing on hormone receptor-positive (HR+) and HER2-negative breast cancer, evaluating novel therapeutic combinations and treatment approaches for advanced and metastatic cases.

• Advanced treatment combinations
• Metastatic disease management
• Hormone therapy resistance

Multiple trials investigating innovative therapeutic options for patients who have progressed after initial treatments.

Research examining new treatments for moderate to severe asthma, including studies of innovative inhaler formulations and delivery systems to improve patient outcomes.

• Asthma management
• Respiratory drug delivery
• Bronchial response studies

Evaluation of advanced inhaler technologies and their safety profiles in controlled asthma patients.

Investigations into treatment options for community-acquired pneumonia (CAP) and COVID-19, testing novel therapeutic approaches in combination with standard care protocols.

• Pneumonia treatment
• COVID-19 interventions
• Immunological responses

Studies focusing on adjunctive treatments to improve outcomes in hospitalized patients.

Advanced research in non-small cell lung cancer (NSCLC) treatment, exploring innovative immunotherapy combinations and targeted therapies for various cancer stages.

• Post-surgical treatment
• Immunotherapy combinations
• Cancer progression prevention

Evaluation of novel therapeutic approaches in cancer treatment following standard interventions.

Innovative research examining treatments for non-alcoholic steatohepatitis (NASH), focusing on improving liver histology and reducing liver-related clinical events.

• Liver disease management
• Fibrosis treatment
• Disease progression prevention

Clinical evaluation of therapeutic interventions for various stages of liver fibrosis.